Finance
Markets
No recent trading data. The last price we hold for HSIC is from Jun 30 (21 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

HSIC

stock Healthcare Medical Distribution
Henry Schein
$83.52 -0.77 (-0.91%) Delayed · quoted 20d ago
Mixed 42% Steady

What the indicators say

Bullish 5 of 5 trend signals bullish
Momentum · RSI 14 Leaning bullish
66
0oversold 30overbought 70100

RSI 66 — firm momentum, not yet overbought.

EMA 21 $80.36
Above
Near-term trend is up
SMA 50 $76.61
Above
Medium-term trend is up
SMA 200 $74.17
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $78.77
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 30

The day open and close within the day's range
Low $83.18 High $84.42
Open
$84.42
+0.15%
Close
$83.52
-0.91%
52-week range where the price sits across its year
52w low $61.95 52w high $89.29
Current
$83.52
Prev close
$84.29
Volume 0.8× the 3-month average
0 avg 2× avg
Today
1.11M
3-mo avg
1.39M

Earningscalendar synced from Yahoo 20d ago

Most recent
May 577 days ago
Next expected
Aug 4in 14 days

Recent earnings dates

  • May 5 77 days ago
  • Feb 24 147 days ago
  • Nov 4, 2025 259 days ago
  • Aug 5, 2025 350 days ago

Past earnings dates come from HSIC’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 20d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), HSIC’s fundamentals read as fair overall.

P/E ratio Fair
25.2x

At 25.2x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Weak
3.0%

A 3.0% margin is thin; little of each revenue dollar survives as profit.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
12.3%

A 12.3% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
3.5%

A 3.5% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Fair
1.98

At 1.98, the company carries a moderate, manageable amount of debt.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.38

At 1.38, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+4.0%

Revenue grew 4.0% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Fair
+2.1%

Net income grew 2.1% from the prior year: steady profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 20d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $12.4B$12.6B$12.3B$12.7B$13.2B
Net income $631.0M$538.0M$416.0M$390.0M$398.0M
Diluted EPS $4.45$3.91$3.16$3.05$3.27
Dividend / share
Total assets $8.5B$8.6B$10.6B$10.2B$11.2B
Total liabilities $3.8B$3.9B$5.4B$5.4B$6.4B
Shareholder equity $3.4B$3.4B$3.7B$3.4B$3.2B

Leadershipsynced from SEC 20d ago

  • Popeck Thomas C CEO, Henry Schein Products
  • South Ronald N. SVP & Chief Financial Officer
  • Ettinger Michael S EVP & Chief Operating Officer
  • Mlotek Mark E EVP, Chief Strategic Officer
  • Murphy Kelly Ann SVP & General Counsel
  • Sheehy Christine Zayac SVP, Chief Human Res. Officer
  • Bergman Stanley M Director
  • Daniel William K Director

Officers and board are drawn from HSIC’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Recent SEC filingssynced from SEC 20d ago